StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/02/2013 -- StockRunway.com issues special report on – Cypress Semiconductor Corporation(NASDAQ:CY), Angie's List Inc(NASDAQ:ANGI), Geron Corporation(NASDAQ:GERN), MannKind Corporation(NASDAQ:MNKD)
Cypress Semiconductor Corporation(NASDAQ:CY) stock is at $9.18, down -1.77 percent from its previous close of $9.345. The stock opened the session at $9.33 and touched its highest price point at $9.4217.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative with -15.7% during previous three months trade. Its recent trading volume was 3.66 million shares in comparison to its usual trading volume of 3.42 million shares. Cypress Semiconductor Corporation (Cypress), delivers high-performance, mixed-signal and programmable solutions.
Has CY Found The Bottom and Ready To Move Up? Find Out Here
Angie's List Inc(NASDAQ:ANGI) stock is at $20.30, down -9.74 percent from its previous close of $9.345. Its today’s volume is 3.66 million shares in comparison to its usual trading volume of 1.26 million shares. The stock opened the session at $22.36 and touched its highest price point at $22.62.
ANGI’s quarterly performance remained red with the percentage of -22.99, while its year to date performance showed that the stock advanced overall +69.31%. Angie’s List, Inc. (Angie’s List) operates a consumer-driven service for members to research, hire, rate and review local professionals for critical needs, such as home, health care and automotive services.
Has ANGI Found The Bottom And Ready To Gain Momentum? Find Out Here
Geron Corporation(NASDAQ:GERN) experienced a plunge of -0.90% to a market valuation of $427.12M per share for previous trading session. After opening the day at $3.31 per share, volume surged to 3.38 million.
During last one month it rose with the percentage of +132.17. Its year to date performance remained progressive with +135.46%. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Why Should Investors Buy GERN After the Recent Fall? Just Go Here and Find Out
MannKind Corporation(NASDAQ:MNKD) opened its shares at the price of $5.74 for the day, its closing price was $5.67 after losing -0.51% for the day. The company traded with the total volume of 3.33 million shares while its average trading aptitude remained 6.11 million shares. The company has total of 301.77 million outstanding shares and its total market capitalization is $1.71 Billion. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company.
Why Should Investors Buy MNKD After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)